US Broker Ratings

Pharvaris N.V. (PHVS) Stock Analysis: A Potential 70% Upside in the Biotech Arena

Pharvaris N.V. (PHVS), a biopharmaceutical company headquartered in Zug, Switzerland, is making waves in the healthcare sector with its innovative approach to tackling rare diseases. Specializing..

Auna SA (AUNA) Stock Analysis: Potential Upside of 89.10% Signals Strong Investment Opportunity

Auna SA (AUNA), a Luxembourg-based healthcare provider with operations extending across Mexico, Peru, and Colombia, is capturing the attention of investors with its promising potential upside..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: 87% Potential Upside Ignites Investor Interest

Taysha Gene Therapies, Inc. (TSHA) is making waves in the biotechnology sector with its impressive potential upside of 87.01%. With an average target price of $9.50,..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Biotech Innovator with 31% Upside Potential

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a promising player in the biotechnology sector, is drawing significant investor interest with its focus on vision-improving therapies. As a biopharmaceutical..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating a Potential 85% Upside in the Healthcare Sector

Investors in the healthcare sector may want to keep an eye on Weave Communications, Inc. (NASDAQ: WEAV), a company that has carved out a niche in..

Immatics N.V. (IMTX) Stock Analysis: Potential 37% Upside in a Promising Biotech Sector

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Tübingen, Germany, is catching the attention of investors with its promising focus on T cell redirecting..

Delcath Systems, Inc. (DCTH) Investor Outlook: Assessing a 96.87% Potential Upside in the Healthcare Sector

Delcath Systems, Inc. (NASDAQ: DCTH), a prominent player in the healthcare sector specializing in medical devices, is captivating investor attention with its significant potential upside of..

Collegium Pharmaceutical, Inc. (COLL) Investor Outlook: Exploring a 34.3% Potential Upside

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stands out in the healthcare sector, particularly in the realm of specialty pharmaceuticals focused on pain management. With a market capitalization..

Owens & Minor, Inc. (OMI) Investor Outlook: Evaluating a 36.89% Potential Upside Amidst Industry Challenges

Owens & Minor, Inc. (NYSE: OMI), a stalwart in the healthcare sector, finds itself navigating a complex landscape as it seeks to leverage its extensive experience..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: A Closer Look at Its Impressive Revenue Growth and Analyst Ratings

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing the attention of investors with its compelling growth story within the healthcare sector. This commercial-stage biopharmaceutical company, specializing..

KalVista Pharmaceuticals (KALV) Stock Analysis: A Biotech Innovator with 187% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is gaining investor attention with its impressive 187.84% potential upside, a figure that stands out in today’s volatile market environment. This..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Unveiling a 101.56% Potential Upside in the Biotech Space

For investors with a keen eye on the biotechnology sector, ArriVent BioPharma, Inc. (NASDAQ: AVBP) presents an intriguing opportunity. A clinical-stage company based in Newtown Square,..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Challenges and Investment Potential

STAAR Surgical Company (NASDAQ: STAA) is a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Lake Forest, California,..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with Strategic Focus in the Medical Devices Sector

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector specializing in medical devices, is currently navigating a series of financial and operational challenges...

Nuvation Bio Inc. (NUVB) Stock Analysis: Unpacking the 124.98% Potential Upside in the Biotech Sphere

Nuvation Bio Inc. (NASDAQ: NUVB) is a name that has been capturing attention in the biotechnology sector, driven by its promising therapeutic pipeline and remarkable potential..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Exploring a Promising 16.14% Upside in the Biotech Arena

Sionna Therapeutics, Inc. (NASDAQ: SION) is capturing investor interest as it navigates the competitive and high-stakes world of biotechnology. Focused on developing innovative treatments for cystic..

Beta Bionics, Inc. (BBNX) Stock Analysis: Healthcare Innovator with a 22.8% Potential Upside

Beta Bionics, Inc. (NASDAQ: BBNX), a cutting-edge company in the healthcare sector, has captured investor attention with its innovative approach to managing diabetes and a notable..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Investor Outlook on a Potential 89.66% Upside

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is garnering attention from investors as a promising player in the biotechnology sector, specifically within the field of cancer treatment. Headquartered..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unpacking a Potential 306% Upside in the Biotech Sector

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) stands at an intriguing crossroads within the biotechnology sector, presenting a compelling case for investors with its substantial potential upside of..

Simulations Plus, Inc. (SLP) Stock Analysis: A 43.57% Potential Upside for Investors in Health Information Services

Simulations Plus, Inc. (NASDAQ: SLP) is capturing investor attention with its promising position in the healthcare sector, specifically within the health information services industry. With an..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds